Mohammad Kamal
Medical Oncology · Ocala, FLNPI 1699975755
Payments from drug & device makers
Across 402 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$778
- Bristol Myers Squibb$599
- Daiichi Sankyo Inc.$545
- Novartis$488
- E.r. Squibb & Sons, L.L.C.$459
- Pfizer$321
- plus $4K from 54 others
What the payments were for
- Food & beverage$7,43399%
- Education$481%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,481 in reported general payments places this provider in the 30th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Ocala
- Rama BalaramanOcala$7.3M
- Zeynep ErogluTampa$30.9M
- Manish PatelSarasota$29.7M
- Jad ChahoudTampa$21.8M
- Maen HusseinTavares$18.4M
- Patrick HwuTampa$18M
- Gail WrightHudson$13.8M
- Adil DaudTampa$13.3M
- Lowell HartFort Myers$10.1M
- Judy WangSarasota$9.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.